Darragh Downey
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Cognitive function after electroconvulsive therapy for depression: relationship to clinical response.
Journal: Psychological medicine
Published: February 28, 2020
Frontal haemodynamic responses in depression and the effect of electroconvulsive therapy.
Journal: Journal of psychopharmacology (Oxford, England)
Published: June 26, 2019
Regional default mode network connectivity in major depressive disorder: modulation by acute intravenous citalopram.
Journal: Translational psychiatry
Published: November 13, 2018
Neural pathways of maternal responding: systematic review and meta-analysis.
Journal: Archives of women's mental health
Published: January 02, 2018
Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial.
Journal: The lancet. Psychiatry
Published: November 03, 2016
Natural variation in maternal sensitivity is reflected in maternal brain responses to infant stimuli.
Journal: Behavioral neuroscience
Published: August 12, 2016
Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: October 28, 2015
Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study).
Journal: BMC psychiatry
Published: September 08, 2015
fMRI and MRS measures of neuroplasticity in the pharyngeal motor cortex.
Journal: NeuroImage
Published: February 18, 2015
Neuronal nitric oxide synthase (NOS1) polymorphisms interact with financial hardship to affect depression risk.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: February 22, 2014
TOMM40 rs2075650 may represent a new candidate gene for vulnerability to major depressive disorder.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: October 04, 2013
Last Updated: 09/26/2026